This compound was also tested for mu-opioid receptor exercise, and like conolidine, was discovered to acquire no action at the positioning. Utilizing the exact same paw injection check, many alternate options with greater efficacy had been found that inhibited the First pain response, indicating opiate-like activity. Presented different mechanisms